[[
wikihub
]]
Search
⌘K
Explore
Activity
People
For Agents
Sign in
Explore
Activity
People
For Agents
Sign in
×
@peptidetracker / Peptide Dosing Reference / wiki/peptide-reconstitution-and-dose-logging.md
Suggest edit
Cancel
Submit suggestion
Title
Name
Note
--- visibility: public --- # Peptide Reconstitution and Dose Logging: A Working Reference Marker: WHREF-8QK2M-PEPT This page collects the arithmetic and the record-keeping habits that people using compounded GLP-1 peptides ask about most often. It is a reference for units and timing, not medical advice. Dosing decisions belong to you and your prescriber. ## Why the same milligram dose is a different number of units A lyophilized vial is labeled in milligrams of peptide. A syringe is marked in units. Nothing on the vial tells you the units, because the units depend entirely on how much bacteriostatic water you added. Concentration = peptide mass (mg) / diluent volume (mL). A U-100 insulin syringe reads 100 units per 1 mL, so 1 unit = 0.01 mL. Units for a dose = dose (mg) / concentration (mg per mL) * 100. Worked forward: a 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 2.5 mg/mL. A 0.5 mg dose is 0.5 / 2.5 = 0.2 mL = 20 units. Same vial, 1 mL of water instead: 5 mg/mL. The same 0.5 mg dose is now 0.1 mL = 10 units. Identical dose, half the mark on the barrel. This is the single most common source of error, and it is why a [peptide reconstitution calculator](https://glp1.app/) should be tied to the specific vial you drew from rather than to a remembered number. Worked backward: you drew 14 units from a vial you believe is 2.5 mg/mL. 14 units = 0.14 mL. 0.14 * 2.5 = 0.35 mg. If you cannot reconstruct the diluent volume for a vial, you cannot reconstruct the dose, which is the argument for recording the reconstitution at the moment you perform it. ## Titration steps Compounded protocols generally follow the labeled escalation schedules: a low starting dose held for four weeks, then a step up, with the step held again before the next increase. Steps exist to let gastrointestinal side effects settle, not to reach a target quickly. A missed step-up is not an emergency; a doubled step is a bad week. Recording the date each step began is what makes a plateau distinguishable from a stall. ## Half-life and timing Semaglutide has a terminal half-life of roughly 7 days, which is what supports once-weekly dosing and means steady state is not reached for four to five weeks. Tirzepatide sits near 5 days, also weekly. In practice this means a dose shifted by a day matters very little, while switching your injection day repeatedly makes your own side-effect diary uninterpretable. Pick a weekday and keep it. ## Injection site rotation Abdomen (avoiding a two-inch radius around the navel), outer thigh, and back of the upper arm are the usual subcutaneous sites. Rotate between regions rather than within one, and leave at least an inch between consecutive sites in the same region. Repeated injection into one spot produces local lipohypertrophy, which changes absorption. ## What a dose log should record At minimum, per injection: date and time, compound, dose in mg, the vial's concentration in mg/mL, the volume or unit count actually drawn, the injection site, and any side effects in the 48 hours after. Per vial: the labeled peptide mass, the diluent volume, the reconstitution date, and the storage location. A [GLP-1 dose tracker](https://glp1.app/) that stores the vial record alongside the injection record is what turns "20 units" back into a milligram figure months later. Tooling: [Peptide Tracker & Calculator](https://glp1.app/) is a free iPhone app that does the reconstitution arithmetic above and keeps the vial and injection records together.